On Tuesday, Ocugen Inc (NASDAQ: OCGN) opened lower -7.35% from the last session, before settling in for the closing price of $0.68. Price fluctuations for OCGN have ranged from $0.64 to $2.11 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 10.65% over the last five years. Company’s average yearly earnings per share was noted 23.08% at the time writing. With a float of $285.71 million, this company’s outstanding shares have now reached $290.26 million.
The firm has a total of 65 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.72%, operating margin of -531.15%, and the pretax margin is -532.51%.
Ocugen Inc (OCGN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ocugen Inc is 1.80%, while institutional ownership is 24.78%. The most recent insider transaction that took place on Nov 26 ’24, was worth 9,095. In this transaction Director of this company bought 10,000 shares at a rate of $0.91, taking the stock ownership to the 10,000 shares. Before that another transaction happened on Nov 22 ’24, when Company’s Director bought 25,000 for $0.91, making the entire transaction worth $22,848. This insider now owns 75,000 shares in total.
Ocugen Inc (OCGN) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.71% during the next five years compared to 41.20% growth over the previous five years of trading.
Ocugen Inc (NASDAQ: OCGN) Trading Performance Indicators
Check out the current performance indicators for Ocugen Inc (OCGN). In the past quarter, the stock posted a quick ratio of 2.58. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 39.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.18, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.25 in one year’s time.
Technical Analysis of Ocugen Inc (OCGN)
Analysing the last 5-days average volume posted by the [Ocugen Inc, OCGN], we can find that recorded value of 3.67 million was lower than the volume posted last year of 4.17 million. As of the previous 9 days, the stock’s Stochastic %D was 28.91%. Additionally, its Average True Range was 0.05.
During the past 100 days, Ocugen Inc’s (OCGN) raw stochastic average was set at 0.95%, which indicates a significant decrease from 3.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.99% in the past 14 days, which was lower than the 65.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7656, while its 200-day Moving Average is $1.1616. Now, the first resistance to watch is $0.6683. This is followed by the second major resistance level at $0.7065. The third major resistance level sits at $0.7281. If the price goes on to break the first support level at $0.6085, it is likely to go to the next support level at $0.5869. Now, if the price goes above the second support level, the third support stands at $0.5487.
Ocugen Inc (NASDAQ: OCGN) Key Stats
There are currently 291,320K shares outstanding in the company with a market cap of 183.30 million. Presently, the company’s annual sales total 6,040 K according to its annual income of -63,080 K. Last quarter, the company’s sales amounted to 1,140 K and its income totaled -12,970 K.
